Enoxaparin for outpatients with COVID-19: 90-day results from the randomised, open-label, parallel-group, multinational, phase III OVID trial
Titel:
Enoxaparin for outpatients with COVID-19: 90-day results from the randomised, open-label, parallel-group, multinational, phase III OVID trial
Auteur:
Voci, Davide Götschi, Andrea Held, Ulrike Bingisser, Roland Colucci, Giuseppe Duerschmied, Daniel Fumagalli, Riccardo M. Gerber, Bernhard Hasse, Barbara Keller, Dagmar I. Konstantinides, Stavros V. Mach, François Rampini, Silvana K. Righini, Marc Robert-Ebadi, Helia Rosemann, Thomas Roth-Zetzsche, Stéphanie Sebastian, Tim Simon, Noemi R. Spirk, David Stortecky, Stefan Vaisnora, Lukas Kucher, Nils Barco, Stefano